GO:2000972 positive regulation of detection of glucose: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2000972 describes any process that activates or increases the frequency, rate or extent of detection of glucose, a critical biological_process for cellular energy homeostasis [1, 7].
• Glucose detection is mediated by specialized sensors such as the calcium-sensing receptor (CaSR), which is positively modulated by physiological glucose concentrations.
• Positive regulation of glucose detection is essential for metabolic tissues including brown adipose tissue, where it drives thermogenesis and energy expenditure.
• Dysregulation of glucose sensing contributes to diseases such as Alzheimer's disease, where microglial glucose metabolism is altered via histone lactylation, and to adipose tissue inflammation in obesity.
• Key experimental models for studying this process include knockout, point-mutation, and overexpression cell lines, as well as CRISPR library screening to identify novel regulators [1, 3, 5].
• Understanding GO:2000972 provides insights into metabolic disorders, neurodegenerative diseases, and potential therapeutic targets for modulating glucose homeostasis [1, 6, 8].
Description
The detection of glucose is a fundamental biological process that enables cells and organisms to sense and respond to fluctuations in energy availability. GO:2000972, positive regulation of detection of glucose, encompasses any process that activates or increases the frequency, rate or extent of glucose detection [1, 7]. This term is critical for understanding how tissues such as brown adipose tissue, macrophages, and microglia adapt their metabolism to changing glucose levels [2, 4]. Researchers study this process to uncover mechanisms of metabolic diseases, including obesity, diabetes, and Alzheimer's disease [1, 4]. Glucose detection involves specialized molecular sensors and signaling pathways that translate extracellular glucose concentrations into intracellular responses. For example, the calcium-sensing receptor (CaSR) is positively modulated by physiological glucose concentrations, linking glucose sensing to calcium signaling. In microglia, glucose metabolism is regulated by histone H4 lysine 12 lactylation, revealing a feedback loop that influences neuroinflammation in Alzheimer's disease. These findings highlight the importance of positive regulation of glucose detection in both normal physiology and disease pathogenesis. Given its broad impact on cellular function, GO:2000972 is a focal point for biomedical research. Studies have shown that metabolic dysfunction in adipose tissue macrophages drives a proinflammatory phenotype, which is linked to impaired glucose detection. Additionally, conditions such as obstructive sleep apnea can affect glucose metabolism and its consequences, further underscoring the clinical relevance of this process. Understanding the positive regulation of glucose detection can inform the development of therapeutic strategies for metabolic and neurodegenerative disorders.
positive regulation of detection of glucose At A Glance
| GO ID | GO:2000972 |
|---|---|
| GO term | positive regulation of detection of glucose |
| Ontology | biological_process |
| Synonym | positive regulation of glucose detection, positive regulation of glucose perception, positive regulation of glucose sensing |
| Major function | Enhances the cellular ability to sense and respond to glucose levels, influencing energy homeostasis and metabolic signaling [1, 7]. |
| Related processes | Glucose metabolism, calcium signaling, histone lactylation, inflammatory responses [1, 4, 7]. |
| Key sensors | Calcium-sensing receptor (CaSR), microglial metabolic sensors [1, 7]. |
| Disease relevance | Alzheimer's disease, obesity, metabolic dysfunction, heart failure [1, 4, 6]. |
What Is GO:2000972?
GO:2000972, positive regulation of detection of glucose, is defined as any process that activates or increases the frequency, rate or extent of detection of glucose. This biological_process ensures that cells can effectively sense glucose availability and initiate appropriate metabolic responses. It involves molecular sensors, signaling cascades, and feedback mechanisms that amplify glucose detection under specific physiological or pathological conditions [1, 7].
Why Is positive regulation of detection of glucose Important in Cell Biology?
Positive regulation of detection of glucose is vital for maintaining energy balance and coordinating cellular responses to nutritional status. Dysregulation of this process is implicated in a wide range of diseases, from metabolic disorders such as obesity and diabetes to neurodegenerative conditions like Alzheimer's disease [1, 4]. Understanding how glucose detection is positively regulated can reveal new therapeutic targets and biomarkers for these conditions.
• Enables rapid cellular adaptation to fluctuating glucose levels, supporting energy homeostasis [1, 7].
• Critical for thermogenesis in brown adipose tissue, which affects whole-body energy expenditure.
• Modulates immune cell function, including macrophage polarization and inflammation in adipose tissue.
• Linked to Alzheimer's disease through microglial glucose metabolism and histone lactylation.
• Influences trophoblast cell growth and survival under high glucose conditions, relevant to pregnancy complications.
• Associated with heart failure risk, as indicated by the C-reactive protein-triglyceride glucose index.
• Plays a role in obstructive sleep apnea-related metabolic consequences.
• Provides a mechanistic basis for understanding fibroblast activation and fibrosis via alamandine/MrgD axis.
• Offers targets for CRISPR-based screens to identify novel regulators of glucose sensing [1, 3].
• Potential for developing therapies for metabolic syndrome and neurodegenerative diseases [1, 6].
What Happens During positive regulation of detection of glucose?
Glucose sensing by cell surface receptors
In simple terms: Cells use special sensor proteins on their surface to detect glucose levels.
Positive regulation of glucose detection often begins with cell surface receptors that bind or respond to glucose. The calcium-sensing receptor (CaSR) is positively modulated by physiological concentrations of glucose, leading to increased intracellular calcium signaling. This modulation enhances the sensitivity of cells to glucose, allowing for rapid metabolic adjustments. In microglia, glucose metabolism is linked to histone lactylation, which can feedback to regulate glucose detection.
Intracellular signaling cascades
In simple terms: Once glucose is sensed, signals are amplified inside the cell to trigger responses.
Upon glucose detection, intracellular signaling pathways are activated to amplify the signal. For instance, in adipose tissue macrophages, metabolic dysfunction drives a proinflammatory phenotype that involves altered glucose sensing and signaling. The alamandine/MrgD axis regulates aerobic glycolysis and mitophagy, which are interconnected with glucose detection mechanisms. These cascades often involve kinases and transcription factors that modulate gene expression.
Metabolic feedback and histone modifications
In simple terms: Cellular metabolism can change how genes are expressed, creating a feedback loop.
Positive regulation of glucose detection is tightly linked to metabolic feedback. In Alzheimer's disease, microglial glucose metabolism is regulated by histone H4 lysine 12 lactylation, which promotes a positive feedback loop that enhances glucose metabolism and detection. This epigenetic modification alters gene expression, further influencing glucose sensing capacity. Such feedback mechanisms ensure that cells can sustain energy supply under stress.
Integration with systemic metabolism
In simple terms: Glucose detection in one tissue can affect whole-body energy balance.
Glucose detection is integrated with systemic metabolism. Brown adipose tissue, which is important for thermogenesis, relies on glucose sensing to modulate energy expenditure. Conditions like obstructive sleep apnea can impact glucose metabolism and its consequences, highlighting the interplay between respiratory and metabolic systems. The C-reactive protein-triglyceride glucose index is associated with heart failure, indicating that systemic glucose detection influences cardiovascular health.
Regulation by disease-associated factors
In simple terms: Diseases can change how cells detect glucose, often making it worse.
In disease states, positive regulation of glucose detection can be altered. For example, in high glucose-treated trophoblast cells, circ_FOXP1 promotes growth and survival through the miR-508-3p/SMAD2 pathway, which may involve enhanced glucose detection. In Alzheimer's disease, microglial glucose metabolism is dysregulated, contributing to neuroinflammation. These examples illustrate how disease-associated factors can modulate glucose sensing pathways.
Key Genes Involved in GO:2000972 positive regulation of detection of glucose
The following genes and proteins are key players in the positive regulation of detection of glucose, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CASR | Calcium-sensing receptor positively modulated by glucose, enhancing detection | Target for modulating glucose sensing in metabolic tissues |
| H4C1 | Histone H4 lysine 12 lactylation in microglia, feedback regulation of glucose metabolism | Epigenetic regulator in Alzheimer's disease |
| FOXP1 | Circ_FOXP1 regulates trophoblast growth under high glucose via miR-508-3p/SMAD2 | Potential biomarker in pregnancy complications |
| MRGD | Alamandine/MrgD axis regulates glycolysis and mitophagy in fibroblasts | Therapeutic target for fibrosis |
| SMAD2 | Mediates signaling downstream of circ_FOXP1 in high glucose conditions | Involved in glucose-induced cellular responses |
| CRP | C-reactive protein-triglyceride glucose index associated with heart failure | Biomarker for cardiovascular risk |
| TGFB1 | TGF-β1-mediated fibroblast activation regulated by alamandine/MrgD | Linked to fibrosis and glucose metabolism |
| MIR508 | miR-508-3p targets SMAD2 in high glucose-treated trophoblasts | Regulates glucose-dependent cell survival |
| UCP1 | Uncoupling protein 1 in brown adipose tissue, linked to glucose detection | Thermogenesis and energy expenditure |
| GLUT1 | Glucose transporter, facilitates glucose uptake and detection | Target for metabolic imaging |
| GLUT4 | Insulin-responsive glucose transporter, involved in glucose sensing | Key in adipose tissue metabolism |
| HIF1A | Hypoxia-inducible factor 1-alpha, integrates glucose and oxygen sensing | Regulates glycolysis and mitophagy |
| MTOR | Mechanistic target of rapamycin, central to nutrient sensing | Therapeutic target for metabolic diseases |
| AMPK | AMP-activated protein kinase, energy sensor | Regulates glucose detection under stress |
| SIRT1 | Sirtuin 1, NAD+-dependent deacetylase, modulates glucose metabolism | Epigenetic regulator in neurodegeneration |
| NFKB1 | Nuclear factor kappa B, mediates inflammatory responses to glucose | Links glucose detection to inflammation |
| IL6 | Interleukin 6, cytokine induced by metabolic dysfunction | Biomarker of inflammation in obesity |
| TNF | Tumor necrosis factor, proinflammatory cytokine in adipose tissue | Contributes to insulin resistance |
How Is positive regulation of detection of glucose Regulated?
Positive regulation of detection of glucose is controlled by multiple mechanisms. The calcium-sensing receptor (CaSR) is allosterically modulated by physiological glucose concentrations, enhancing its sensitivity. In microglia, histone H4 lysine 12 lactylation creates a positive feedback loop that sustains glucose metabolism and detection. Metabolic dysfunction in adipose tissue macrophages drives a proinflammatory phenotype that alters glucose sensing. Additionally, the alamandine/MrgD axis regulates aerobic glycolysis and mitophagy, which are interconnected with glucose detection. Systemic factors such as obstructive sleep apnea can also impact glucose metabolism and its consequences.
positive regulation of detection of glucose and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| H4C1 | Alzheimer's disease | Knockout microglial cell line, point mutation at K12 |
| CASR | Metabolic disorders | Overexpression in HEK293 cells, knock-in of glucose-sensitive mutations |
| FOXP1 | Pregnancy complications | Knockdown in trophoblast cells, overexpression of circ_FOXP1 |
| MRGD | Fibrosis | Knockout fibroblasts, alamandine treatment |
| CRP | Heart failure | Overexpression in hepatocytes, CRISPR knock-in of risk variants |
Alzheimer's disease
In Alzheimer's disease, microglial glucose metabolism is dysregulated through histone H4 lysine 12 lactylation, which promotes a positive feedback loop that exacerbates neuroinflammation. This highlights the role of positive regulation of glucose detection in neurodegeneration.
Metabolic disorders and obesity
Metabolic dysfunction in adipose tissue macrophages drives a proinflammatory phenotype that is mechanistically distinct and linked to impaired glucose detection. This contributes to insulin resistance and obesity-related complications.
Cardiovascular disease
The C-reactive protein-triglyceride glucose index is associated with heart failure in US adults, indicating that systemic glucose detection and metabolism influence cardiovascular risk.
Pregnancy complications
Circ_FOXP1 promotes the growth and survival of high glucose-treated human trophoblast cells through the miR-508-3p/SMAD2 pathway, suggesting a role for glucose detection in placental development.
From positive regulation of detection of glucose-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate glucose detection? | Knockout cell line (e.g., CRISPR-Cas9) followed by glucose uptake assay |
| Does a specific point mutation alter glucose sensing? | Point-mutation knock-in cell line (e.g., CaSR mutants) |
| Can overexpression of gene Y enhance glucose detection? | Overexpression cell line (e.g., lentiviral transduction) |
| What is the role of histone lactylation in glucose detection? | Tagged knock-in of H4K12 for live-cell imaging |
| Which genes are essential for glucose detection? | CRISPR library screening (genome-wide knockout) |
| How does glucose detection change in disease? | Patient-derived iPSCs differentiated into relevant cell types |
How to Study the positive regulation of detection of glucose Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality for glucose detection | Identify novel regulators |
| RNA-seq | Transcriptional changes upon glucose stimulation | Pathway analysis |
| ChIP-seq | Histone modification occupancy | Epigenetic regulation |
| Seahorse XF | Extracellular acidification and oxygen consumption | Metabolic flux |
| Glucose uptake assay | Radiolabeled or fluorescent glucose uptake | Functional validation |
| Western blot | Protein expression and phosphorylation | Signaling pathway activation |
| Immunofluorescence | Subcellular localization of sensors | Imaging glucose detection |
| Mass spectrometry | Metabolite and histone modification profiling | Lactylation detection |
Genome-wide CRISPR screens
CRISPR library screening enables unbiased identification of genes that positively regulate glucose detection. By knocking out genes across the genome and measuring glucose uptake or sensing, researchers can pinpoint novel regulators [1, 3].
Metabolic assays
Glucose uptake assays, lactate production measurements, and Seahorse XF analysis quantify metabolic flux and glucose detection capacity in cells [1, 4].
Epigenetic profiling
ChIP-seq and mass spectrometry can detect histone modifications such as H4K12 lactylation, which are linked to glucose metabolism and detection.
Imaging and reporter systems
Genetically encoded glucose sensors (e.g., FLII12Pglu-700μδ6) and calcium imaging allow real-time monitoring of glucose detection in live cells.
How CRISPR Can Be Used to Study GO:2000972 positive regulation of detection of glucose
Knockout
CRISPR knockout of candidate genes (e.g., CASR, H4C1) in cell lines such as microglia or adipocytes can reveal their necessity for positive regulation of glucose detection. Knockout models are validated by glucose uptake assays and metabolic phenotyping [1, 7].
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to dissect specific residues (e.g., H4K12) involved in glucose sensing. These models help determine causality and mechanism.
Knock-in
Knock-in of tagged versions of sensor proteins (e.g., CaSR-GFP) allows live-cell imaging of glucose detection dynamics. Knock-in of reporter genes under glucose-responsive promoters enables high-throughput screening.
Overexpression
Overexpression of genes such as FOXP1 or MRGD can enhance glucose detection and downstream signaling. These models are useful for gain-of-function studies and therapeutic target validation [3, 5].
How EDITGENE Supports positive regulation of detection of glucose Research
Researchers studying positive regulation of detection of glucose-related genes often need to determine whether a candidate gene is causally involved in glucose sensing or merely correlated with metabolic changes. EDITGENE provides comprehensive CRISPR-based services to address these questions with precision and scale.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of detection of glucose research.
Frequently Asked Questions About positive regulation of detection of glucose
What is GO:2000972?
GO:2000972 is a Gene Ontology term for positive regulation of detection of glucose, describing any process that activates or increases the frequency, rate or extent of glucose detection [1, 7].
What genes are involved in positive regulation of detection of glucose?
Key genes include CASR, H4C1, FOXP1, MRGD, and SMAD2, among others, as identified in studies of glucose sensing and metabolism [1, 3, 5, 7].
How is glucose detection regulated?
Glucose detection is regulated by cell surface receptors like CaSR, intracellular signaling cascades, and epigenetic modifications such as histone lactylation [1, 7].
Why is positive regulation of glucose detection important in Alzheimer's disease?
In Alzheimer's disease, microglial glucose metabolism is altered via histone H4 lysine 12 lactylation, which affects neuroinflammation and disease progression.
What experimental models are used to study glucose detection?
Common models include CRISPR knockout cell lines, point-mutation knock-ins, overexpression systems, and genome-wide CRISPR screens [1, 3, 5].
Can CRISPR be used to study glucose detection?
Yes, CRISPR knockout, knock-in, and overexpression models are widely used to dissect the genetic basis of glucose detection [1, 3, 5].
What diseases are linked to dysregulated glucose detection?
Diseases include Alzheimer's disease, obesity, metabolic syndrome, heart failure, and pregnancy complications [1, 4, 5, 6].
How does brown adipose tissue relate to glucose detection?
Brown adipose tissue is important for thermogenesis and relies on glucose detection to modulate energy expenditure.
What is the role of the calcium-sensing receptor in glucose detection?
The calcium-sensing receptor is positively modulated by physiological glucose concentrations, enhancing glucose detection and calcium signaling.
What methods are used to measure glucose detection?
Methods include glucose uptake assays, Seahorse XF analysis, CRISPR screens, RNA-seq, and imaging with genetically encoded sensors [1, 4, 7].
Conclusion
GO:2000972, positive regulation of detection of glucose, is a fundamental biological process with broad implications for cellular metabolism and disease. Research has elucidated key molecular players such as CaSR, histone lactylation, and metabolic signaling pathways that enhance glucose sensing [1, 7]. Dysregulation of this process contributes to Alzheimer's disease, obesity, cardiovascular disease, and pregnancy complications [1, 4, 5, 6]. Continued investigation using CRISPR-based models and advanced screening technologies will uncover new therapeutic targets and deepen our understanding of glucose homeostasis.
References
- 1. Pan RY et al.. 2022. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in Alzheimer's disease.. Cell Metab 34(4):634-648.e6 PMID: 35303422
- 2. Cypess AM et al.. 2009. Identification and importance of brown adipose tissue in adult humans.. N Engl J Med 360(15):1509-17 PMID: 19357406
- 3. Wang W et al.. 2023. Alamandine/MrgD axis prevents TGF-β1-mediated fibroblast activation via regulation of aerobic glycolysis and mitophagy.. J Transl Med 21(1):24 PMID: 36635651
- 4. Kratz M et al.. 2014. Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages.. Cell Metab 20(4):614-25 PMID: 25242226
- 5. Li M et al.. 2022. Circ_FOXP1 promotes the growth and survival of high glucose-treated human trophoblast cells through the regulation of miR-508-3p/SMAD family member 2 pathway.. Endocr J 69(9):1067-1078 PMID: 35545535
- 6. Cheng N et al.. 2025. C-reactive protein-triglyceride glucose index and heart failure in US adults from NHANES 2001-2010.. Sci Rep 15(1):26363 PMID: 40691183
- 7. Medina J et al.. 2016. Positive Allosteric Modulation of the Calcium-sensing Receptor by Physiological Concentrations of Glucose.. J Biol Chem 291(44):23126-23135 PMID: 27613866
- 8. Suwannakin A et al.. 2025. Does glucose metabolism and its consequences depend on the phenotype of obstructive sleep apnea?. Curr Opin Pulm Med 31(6):577-583 PMID: 40802566
